1. |
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2 416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet, 2017, 390(10113): 2627-2642.
|
2. |
GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med, 2017, 377(1): 13-27.
|
3. |
Wang Y, Xue H, Sun M, et al. Prevention and control of obesity in China. Lancet Glob Health, 2019, 7(9): e1166-e1167. doi: 10.1016/S2214-109X(19)30276-1.
|
4. |
Hanipah ZN, Schauer PR. Surgical treatment of obesity and diabetes. Gastrointest Endosc Clin N Am, 2017, 27(2): 191-211.
|
5. |
Velapati SR, Shah M, Kuchkuntla AR, et al. Weight regain after bariatric surgery: prevalence, etiology, and treatment. Curr Nutr Rep, 2018, 7(4): 329-334.
|
6. |
胡敬尧, 刘金钢. 减重代谢手术的“经典与创新”. 中华内分泌外科杂志, 2020, 14(6): 441-444.
|
7. |
大中华减重与代谢手术数据库研究者团队. 大中华减重与代谢手术数据库2020年度报. 中国实用外科杂志, 2021, 41(5): 533-542.
|
8. |
de Moura DTH, Barrichello S, de Moura EGH, et al. Endoscopic sleeve gastroplasty in the management of weight regain after sleeve gastrectomy. Endoscopy, 2020, 52(3): 202-210.
|
9. |
Cheung D, Switzer NJ, Gill RS, et al. Revisional bariatric surgery following failed primary laparoscopic sleeve gastrectomy: a systematic review. Obes Surg, 2014, 24(10): 1757-1763.
|
10. |
Casella G, Soricelli E, Giannotti D, et al. Long-term results after laparoscopic sleeve gastrectomy in a large monocentric series. Surg Obes Relat Dis, 2016, 12(4): 757-762.
|
11. |
Martin MJ, Topart P. Comment on: “Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: an audit of 34 patients” and “Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass—10-year results of laparoscopic sleeve gastrectomy”. Surg Obes Relat Dis, 2016, 12(9): 1651-1654.
|
12. |
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet, 2015, 386(9997): 964-973.
|
13. |
Roth AE, Thornley CJ, Blackstone RP. Outcomes in bariatric and metabolic surgery: an updated 5-year review. Curr Obes Rep, 2020, 9(3): 380-389.
|
14. |
Pereira SS, Jarak I, Carvalho RA, et al. Different malabsorptive obesity surgery interventions result in distinct postprandial amino acid metabolomic signatures. Obes Surg, 2020, 30(10): 4019-4028.
|
15. |
Topart P, Becouarn G, Finel JB. Is transit bipartition a better alternative to biliopancreatic diversion with duodenal switch for superobesity? Comparison of the early results of both procedures. Surg Obes Relat Dis, 2020, 16(4): 497-502.
|
16. |
Spinos D, Skarentzos K, Esagian SM, et al. The effectiveness of single-anastomosis duodenoileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS): an updated systematic review. Obes Surg, 2021, 31(4): 1790-1800.
|
17. |
Finno P, Osorio J, García-Ruiz-de-Gordejuela A, et al. Single versus double-anastomosis duodenal switch: single-site comparative cohort study in 440 consecutive patients. Obes Surg, 2020, 30(9): 3309-3316.
|
18. |
Mahdy T, Al Wahedi A, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: a retrospective cohort study. Int J Surg, 2016, 34: 28-34.
|
19. |
Khalaf M, Hamed H. Single-anastomosis sleeve ileal (SASI) bypass: hopes and concerns after a two-year follow-up. Obes Surg, 2021, 31(2): 667-674.
|
20. |
郭沛, 侯栋升, 姚立彬, 等. 胃旁路手术切除残胃对肥胖合并2型糖尿病大鼠减重及糖代谢的影响. 中国普外基础与临床杂志, 2021, 28(10): 1280-1286.
|
21. |
Søvik TT, Aasheim ET, Taha O, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med, 2011, 155(5): 281-291.
|
22. |
Nett P, Borbély Y, Kröll D. Micronutrient supplementation after biliopancreatic diversion with duodenal switch in the long term. Obes Surg, 2016, 26(10): 2469-2474.
|
23. |
Shoar S, Poliakin L, Rubenstein R, et al. Single anastomosis duodeno-ileal switch (SADIS): a systematic review of efficacy and safety. Obes Surg, 2018, 28(1): 104-113.
|
24. |
Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg, 2012, 256(1): 104-110.
|
25. |
Ece I, Yilmaz H, Yormaz S, et al. The short-term effects of transit bipartition with sleeve gastrectomy and distal-Roux-en-Y gastric bypass on glycemic control, weight loss, and nutritional status in morbidly obese and type 2 diabetes mellitus patients. Obes Surg, 2021, 31(5): 2062-2071.
|
26. |
Chen G, Zhang GX, Peng BQ, et al. Roux-en-Y gastric bypass versus sleeve gastrectomy plus procedures for treatment of morbid obesity: systematic review and meta-analysis. Obes Surg, 2021, 31(7): 3303-3311.
|
27. |
Mahdy T, Gado W, Alwahidi A, et al. Sleeve gastrectomy, one-anastomosis gastric bypass (OAGB), and single anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity: a retrospective cohort study. Obes Surg, 2021, 31(4): 1579-1589.
|
28. |
傅涛, 金炜东. 肥胖症与2型糖尿病的外科治疗机制研究进展. 中华普外科手术学杂志(电子版), 2020, 14(6): 639-642.
|
29. |
Webb DL, Abrahamsson N, Sundbom M, et al. Bariatric surgery—time to replace with GLP-1? Scand J Gastroenterol, 2017, 52(6-7): 635-640.
|
30. |
Hutch CR, Sandoval D. The role of GLP-1 in the metabolic success of bariatric surgery. Endocrinology, 2017, 158(12): 4139-4151.
|
31. |
Smith EP, Polanco G, Yaqub A, et al. Altered glucose metabolism after bariatric surgery: what’s GLP-1 got to do with it? Metabolism, 2018, 83: 159-166.
|
32. |
Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg, 2010, 252(6): 966-971.
|
33. |
Fosgerau K, Jessen L, Lind Tolborg J, et al. The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice. Diabetes Obes Metab, 2013, 15(1): 62-71.
|
34. |
杜植鹏. 糖尿病大鼠袖状胃切除术后胃肠动力改变及对GLP-1分泌的影响. 上海: 第二军医大学, 2017.
|
35. |
Ramos-Leví AM, Sánchez-Pernaute A, Marcuello C, et al. Glucose variability after bariatric surgery: is prediction of diabetes remission possible? Obes Surg, 2017, 27(12): 3341-3343.
|
36. |
Andalib A, Bouchard P, Alamri H, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S): short-term outcomes from a prospective cohort study. Surg Obes Relat Dis, 2021, 17(2): 414-424.
|
37. |
Kermansaravi M, Kabir A, Pazouki A. 1-year follow-up of single anastomosis sleeve ileal (SASI) bypass in morbid obese patients: efficacy and concerns. Obes Surg, 2020, 30(11): 4286-4292.
|
38. |
郑莉, 马颖璋, 陆佳军, 等. 腹腔镜胃袖状切除术对肥胖症患者营养状况的影响. 中华临床营养杂志, 2017, 25(4): 221-225.
|
39. |
Santoro S. From bariatric to pure metabolic surgery: new concepts on the rise. Ann Surg, 2015, 262(2): e79-e80. doi: 10.1097/SLA.0000000000000590.
|
40. |
Felsenreich DM, Ladinig LM, Beckerhinn P, et al. Update: 10 years of sleeve gastrectomy—the first 103 patients. Obes Surg, 2018, 28(11): 3586-3594.
|
41. |
Emile SH, Madyan A, Mahdy T, et al. Single anastomosis sleeve ileal (SASI) bypass versus sleeve gastrectomy: a case-matched multicenter study. Surg Endosc, 2021, 35(2): 652-660.
|
42. |
Andreollo NA, Santos EF, Araújo MR, et al. Rat’s age versus human’s age: what is the relationship? Arq Bras Cir Dig, 2012, 25(1): 49-51.
|
43. |
Sengupta P. The laboratory rat: relating its age with human’s. Int J Prev Med, 2013, 4(6): 624-630.
|
44. |
Lupoli R, Lembo E, Saldalamacchia G, et al. Bariatric surgery and long-term nutritional issues. World J Diabetes, 2017, 8(11): 464-474.
|